Artificial Intelligence In Pharmaceutical Market

Artificial Intelligence In Pharmaceutical Market Research Report: Size, Share, Trend Analysis By Technology (Machine Learning, Natural Language Processing, Computer Vision, Other Technologies), By Applications (Drug Discovery and Development, Clinical Trials, Manufacturing and Supply Chain, Marketing and Sales, Other Applications), By Deployment Model (Cloud-Based, On-Premise, Hybrid), By End-User (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutions, Healthcare Providers) - Growth Outlook & Industry Forecast 2025 To 2035
ID: MRFR/HC/25130-HCR
100 Pages
Satyendra Maurya, Rahul Gotadki
Last Updated: July 16, 2026
Artificial Intelligence In Pharmaceutical Market
Market Size
Forecast Period2025-2035
CAGR (2025-2035)19.43%
2024 Market Size$ 1.49 Billion
2025 Market Size$ 1.78 Billion
2035 Market Size$ 10.51 Billion
Key Players
IBM
Microsoft
Google
Amazon
Oracle
Sanofi
Trends
  • AI-Accelerated Drug Discovery
  • Strategic AI Partnerships and Investments
Opportunities
  • Rising Demand for Drug Discovery
Request Free Sample

Artificial Intelligence In Pharmaceutical Market Summary

The Global Artificial Intelligence In Pharmaceutical Market is poised for substantial growth, expanding from 1.49 USD Billion in 2024 to 10.51 USD Billion by 2035.

Key Market Trends & Highlights

Artificial Intelligence In Pharmaceutical Market Key Trends and Highlights

  • The market is expected to grow at a compound annual growth rate (CAGR) of 21.37% from 2025 to 2032.
  • By 2035, the market valuation is projected to reach 12.5 USD Billion, indicating a robust upward trajectory.
  • in 2024, the market is valued at 1.49 USD Billion, laying a strong foundation for future expansion.
  • Growing adoption of artificial intelligence technologies due to increased efficiency in drug discovery is a major market driver.

Market Size & Forecast

2024 Market Size 1.49 (USD Billion)
2035 Market Size 10.51 (USD Billion)
CAGR (2025-2035) 19.43%

Major Players

IBM, Microsoft, Google, Amazon, Oracle, Sanofi, Aventis, Bayer, AstraZeneca, NVIDIA, Roche, Pfizer, Novartis

Artificial Intelligence In Pharmaceutical Market Drivers

Rising Demand for Drug Discovery

The Global Artificial Intelligence In Pharmaceutical Market Industry experiences a notable surge in demand for drug discovery solutions. AI technologies streamline the drug development process, significantly reducing time and costs associated with traditional methods. For instance, AI can analyze vast datasets to identify potential drug candidates, which accelerates the initial phases of research. As of 2024, the market is valued at approximately 1.49 USD Billion, reflecting the growing reliance on AI for efficient drug discovery. This trend is expected to continue, with projections indicating a market expansion to 12.5 USD Billion by 2035, driven by a compound annual growth rate of 21.37% from 2025 to 2035.

Market Segment Insights

By Technology: Machine Learning (Largest) vs. Natural Language Processing (Fastest-Growing)

Machine Learning dominates the Artificial Intelligence in Pharmaceutical Market, providing robust solutions that streamline drug discovery, optimize clinical trials, and improve patient outcomes. Its ability to analyze large datasets enhances operational efficiency and decision-making across pharmaceutical research and development. Meanwhile, Natural Language Processing is rapidly emerging as a key growth area by enabling the analysis of unstructured data such as clinical notes and research publications, supporting informed decision-making and personalized medicine initiatives. The growing need for automation, predictive analytics, and efficient data interpretation continues to strengthen the adoption of both technologies, with Machine Learning maintaining its leadership position while Natural Language Processing gains increasing momentum.

By Application: Drug Discovery and Development (Largest) vs. Clinical Trials (Fastest-Growing)

Drug Discovery and Development represents the largest application segment in the Artificial Intelligence in Pharmaceutical Market, driven by AI's ability to accelerate candidate identification, reduce development timelines, and improve research efficiency. Clinical Trials are emerging as the fastest-growing application, supported by AI-powered patient recruitment, real-time data analysis, and adaptive trial management. As pharmaceutical companies increasingly invest in AI-driven research, both segments continue to benefit from improved operational efficiency, enhanced decision-making, and faster development of innovative therapies.

By Deployment Model: Cloud-Based (Largest) vs. On-Premise (Fastest-Growing)

Cloud-Based deployment holds the largest share in the Artificial Intelligence in Pharmaceutical Market due to its scalability, flexibility, and cost-effectiveness, making it the preferred choice for pharmaceutical organizations implementing AI solutions. On-Premise deployment is witnessing rapid growth as companies prioritize greater control over sensitive healthcare data, regulatory compliance, and data security. While cloud platforms continue to support collaboration and large-scale analytics, on-premise solutions are increasingly adopted by organizations requiring enhanced infrastructure control and privacy protection.

By End-User: Pharmaceutical Companies (Largest) vs. Biotechnology Companies (Fastest-Growing)

Pharmaceutical Companies account for the largest share of the market, leveraging AI technologies across drug discovery, clinical development, and personalized medicine initiatives. Biotechnology Companies are rapidly expanding their AI adoption to accelerate compound screening, improve research efficiency, and develop innovative therapeutic solutions. Increased investments, technological advancements, and the growing need for faster drug development continue to support the expansion of both end-user segments.

By Data Type: Structured Data (Largest) vs. Unstructured Data (Fastest-Growing)

Structured Data remains the dominant data type in the Artificial Intelligence in Pharmaceutical Market due to its standardized format, enabling efficient processing, predictive analytics, and integration into AI algorithms. Unstructured Data is gaining significant traction as advances in machine learning and natural language processing enable pharmaceutical companies to extract valuable insights from clinical notes, medical images, research publications, and other text-based information. The increasing utilization of diverse data sources is expected to further strengthen AI-driven innovation and personalized medicine capabilities.

Get more detailed insights about Artificial Intelligence In Pharmaceutical Market
Request Free Sample

Key Players and Competitive Insights

Major players in Artificial Intelligence In the Pharmaceutical Market industry are continuously competing to enhance their product lines and services to stay ahead of the competition. Leading Artificial Intelligence In Pharmaceutical Market players are expanding their footprints by expanding their presence in new regions and collaborating with other companies. Artificial Intelligence In Pharmaceutical Market development is primarily focused on R&D activities and strategic partnerships. The Artificial Intelligence In Pharmaceutical Market Competitive Landscape is fragmented, with a number of small and medium-sized players competing for a share of the market. Key players in artificial intelligence in the Pharmaceutical Market include IBM, Microsoft, Google, Amazon, and Oracle. These companies are investing heavily in R&D to develop new and innovative Artificial Intelligence In Pharmaceutical Market products and services. They are also forming partnerships with other companies to expand their reach and gain access to new markets.IBM is a leading provider of Artificial Intelligence In Pharmaceutical Market products and services. The company offers a wide range of solutions, including software, hardware, and services. IBM's Watson AI platform is a key component of its Artificial Intelligence In Pharmaceutical Market offerings.Watson is a cognitive computing platform that can be used to develop a variety of applications, including those for drug discovery, clinical trials, and patient management. Microsoft is another major player in artificial intelligence in the Pharmaceutical Market. The company offers a range of products and services, including the Azure AI platform. Azure AI is a cloud-based platform that provides developers with a variety of tools and services for developing and deploying AI applications. Microsoft is also working with a number of pharmaceutical companies to develop new AI-based solutions for the industry.Google is a leading provider of cloud-based services. The company offers a range of products and services that can be used to develop and deploy AI applications.Google Cloud AI is a cloud-based platform that provides developers with a variety of tools and services for developing and deploying AI applications. Google is also working with a number of pharmaceutical companies to develop new AI-based solutions for the industry. Amazon is a leading provider of cloud-based services. The company offers a range of products and services that can be used to develop and deploy AI applications. Amazon Web Services (AWS) is a cloud-based platform that provides developers with a variety of tools and services for developing and deploying AI applications. Amazon is also working with a number of pharmaceutical companies to develop new AI-based solutions for the industry. Oracle is a leading provider of software and services. The company offers a range of products and services that can be used to develop and deploy AI applications.Oracle's AI platform is a key component of its Artificial Intelligence In Pharmaceutical Market offerings. Oracle's AI platform provides developers with a variety of tools and services for developing and deploying AI applications. Oracle is also working with a number of pharmaceutical companies to develop new AI-based solutions for the industry.

Key Companies in the Artificial Intelligence In Pharmaceutical Market include

Industry Developments

  • Q2 2024: Sanofi, Formation Bio and OpenAI partner to build AI-powered software for drug development Sanofi announced a partnership with Formation Bio and OpenAI to develop custom AI software aimed at accelerating drug development, marking a significant collaboration between a major pharmaceutical company and leading AI technology firms.
  • Q2 2024: AstraZeneca Invests in AI Startup Absci to Accelerate Drug Discovery AstraZeneca made a strategic investment in Absci, an AI-driven drug discovery startup, to leverage Absci’s generative AI platform for designing new biologic drug candidates.
  • Q2 2024: Insilico Medicine Announces $80 Million Series D Funding to Advance AI-Driven Drug Discovery Insilico Medicine raised $80 million in Series D funding to further develop its end-to-end AI drug discovery platform and expand its pipeline of novel therapeutics.
  • Q3 2024: Pfizer and Tempus Announce Strategic Collaboration to Leverage AI for Oncology Drug Development Pfizer and Tempus entered a strategic collaboration to use Tempus’ AI and data analytics platform to accelerate the development of new oncology therapies.
  • Q2 2024: Exscientia and Merck KGaA Sign Multi-Year AI Drug Discovery Partnership Exscientia and Merck KGaA signed a multi-year partnership to use Exscientia’s AI platform for the discovery of novel small molecule drug candidates across multiple therapeutic areas.
  • Q1 2025: Recursion Pharmaceuticals Announces FDA Clearance of IND Application for AI-Designed Drug Recursion Pharmaceuticals received FDA clearance for its Investigational New Drug (IND) application for a novel therapy designed using its proprietary AI platform.
  • Q2 2025: Bayer Launches AI Innovation Lab for Pharmaceutical R&D in Berlin Bayer opened a new AI innovation lab in Berlin dedicated to accelerating pharmaceutical research and development through advanced machine learning and data analytics.
  • Q2 2024: BenchSci Raises $95 Million Series D to Expand AI-Driven Preclinical R&D Platform BenchSci secured $95 million in Series D funding to scale its AI-powered platform that accelerates preclinical research and drug discovery for pharmaceutical companies.
  • Q3 2024: GSK and PathAI Announce Partnership to Advance AI-Powered Biomarker Discovery GSK and PathAI formed a partnership to use PathAI’s machine learning technology for biomarker discovery and patient stratification in clinical trials.
  • Q1 2025: Novartis Appoints Chief AI Officer to Lead Digital Transformation in Drug Development Novartis appointed its first Chief AI Officer to oversee the integration of artificial intelligence across its drug development and clinical operations.
  • Q2 2025: Eli Lilly Acquires AI Drug Discovery Startup Cyclica for $250 Million Eli Lilly acquired Cyclica, a Toronto-based AI drug discovery company, to enhance its capabilities in computational drug design and accelerate its R&D pipeline.
  • Q2 2024: Roche and Genentech Launch AI-Driven Platform for Personalized Medicine Roche and Genentech launched a new AI-powered platform designed to support personalized medicine initiatives by integrating genomic, clinical, and real-world data.

Future Outlook

Artificial Intelligence In Pharmaceutical Market Future Outlook

The Artificial Intelligence in Pharmaceutical Market is poised for growth at 19.43% CAGR from 2024 to 2032, driven by advancements in drug discovery, personalized medicine, and operational efficiencies.

New opportunities lie in:

  • Develop AI-driven platforms for predictive analytics in clinical trials. Invest in AI solutions for drug repurposing and optimization. Create partnerships with tech firms to enhance AI capabilities in pharmaceutical research.

By 2035, the market is expected to reach unprecedented levels, reflecting robust innovation and strategic partnerships.

Market Segmentation

Artificial Intelligence In Pharmaceutical Market End-User Outlook

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutions
  • Healthcare Providers
  • Other End-Users

Artificial Intelligence In Pharmaceutical Market Data Type Outlook

  • Structured Data
  • Unstructured Data
  • Both Structured and Unstructured Data

Artificial Intelligence In Pharmaceutical Market Technology Outlook

  • Machine Learning
  • Natural Language Processing
  • Computer Vision
  • Other Technologies

Artificial Intelligence In Pharmaceutical Market Application Outlook

  • Drug Discovery and Development
  • Clinical Trials
  • Manufacturing and Supply Chain
  • Marketing and Sales
  • Other Applications

Artificial Intelligence In Pharmaceutical Market Deployment Model Outlook

  • Cloud-Based
  • On-Premise
  • Hybrid

Report Scope

Report Attribute/Metric Details
Market Size 2024 1.49 (USD Billion)
Market Size 2035 10.51 (USD Billion)
Compound Annual Growth Rate (CAGR) 19.43% (2025 - 2035)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year 2024
Market Forecast Period 2025 - 2035
Historical Data 2018-2022
Market Forecast Units USD Billion
Key Companies Profiled Sanofi Aventis, Microsoft, Bayer, Google, IBM, AstraZeneca, NVIDIA, Amazon, Roche, Pfizer, Novartis
Segments Covered Technology, Application, Deployment Model, End-User, Data Type, Regional
Key Market Opportunities Precision Medicine Drug Discovery Optimization Clinical Trial Management Personalized Treatment Plans Remote Patient Monitoring
Key Market Dynamics Growing demand for personalized medicine Increasing adoption of AI in drug discovery Advancements in machine learning and deep learning Government initiatives and funding Strategic partnerships and collaborations.
Countries Covered North America, Europe, APAC, South America, MEA
Market Size 2025 1.78 (USD Billion)

FAQs

What is the projected growth of the Artificial Intelligence In Pharmaceutical market?
The Artificial Intelligence In Pharmaceutical market is the expected increase in total market value of 10.51 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.
What is the size of the Artificial Intelligence In Pharmaceutical market?
Artificial Intelligence In Pharmaceutical market size was valued at approximately 1.49 billion USD in 2024. This figure will reach 10.51 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.
What is the CAGR of the Artificial Intelligence In Pharmaceutical market?
Artificial Intelligence In Pharmaceutical market is expected to grow at a CAGR of 19.43% between 2025 and 2035.
How much will the Artificial Intelligence In Pharmaceutical market be worth by 2035?
Artificial Intelligence In Pharmaceutical market is expected to be worth of 10.51 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.
How will the Artificial Intelligence In Pharmaceutical market perform over the next 10 years?
Over the next 10 years the Artificial Intelligence In Pharmaceutical market is expected to shift from usd billion 1.49 to 10.51 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.
What is the regional breakdown of the Artificial Intelligence In Pharmaceutical Market?
North America held the largest share of AI in the pharmaceutical market and is expected to maintain its dominance throughout the forecast period. Europe is projected to witness a significant growth rate owing to the increasing adoption of AI in drug discovery and development.
What are the key drivers of the Artificial Intelligence In Pharmaceutical Market?
Major factors driving the growth of AI in the pharmaceutical market include the rising demand for personalized medicine, the need for faster and more efficient drug discovery and development processes, and the increasing adoption of AI in clinical trials.
What are the key applications of Artificial Intelligence in the Pharmaceutical Industry?
Key applications of AI in the pharmaceutical industry include drug discovery, clinical trials, personalized medicine, and manufacturing.
Who are the major competitors in the Artificial Intelligence In Pharmaceutical Market?
Major players operating in the Global AI in the Pharmaceutical Market include IBM, Microsoft, Google, Amazon, and Oracle.
What is the outlook for the Artificial Intelligence In Pharmaceutical Market?
The Global AI in Pharmaceutical Market is expected to witness substantial growth over the forecast period, driven by factors such as the increasing adoption of AI in drug discovery and development, the rising demand for personalized medicine, and the growing need for faster and more efficient clinical trials.
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.